{
  "schemaVersion": 1,
  "capturedAt": "2026-11-13T05:44:15.579Z",
  "sha256": "1e35bea66dcbeca2a9f7a18d82758fd74742c291cc74a0a88ddd375ce7282e63",
  "work": {
    "type": "RDN",
    "kind": "note",
    "key": "trommelen-2023",
    "id": "TAP-RDN-0083",
    "locale": "zh",
    "path": "/zh/research/trommelen-2023/",
    "title": "TAP 导读: The anabolic response to protein ingestion during recovery from exercise has no upper limit in magnitude and duration in vivo in humans",
    "description": "一次抗阻运动后，100 g乳蛋白相较25 g，在12小时观察期内带来更大、更持久的蛋白合成反应。这对该条件下“超过20–30 g便无法利用”的固定上限提出挑战。",
    "rights": "© The Allostasis Project。保留所有权利。除法律允许的例外外，转载或改编需另行授权。",
    "version": "1.0",
    "updatedAt": "2026-11-13",
    "editorial": {
      "contentType": "evidence-review",
      "reviewState": "draft",
      "reviewedAt": null,
      "reviewedVersion": null,
      "updatedAt": "2026-11-13",
      "version": "1.0",
      "byline": "team",
      "author": null,
      "reviewer": null,
      "workflow": {
        "ai": {
          "usage": "used",
          "system": "OpenAI Codex",
          "scope": "基于来源进行证据综合、写作与翻译；实际查阅材料及获取范围见各文献导读。",
          "version": "1.0",
          "tasks": [
            "Literature comparison and evidence extraction",
            "Bilingual explanatory writing and source-linked tables"
          ]
        }
      },
      "revisions": []
    },
    "original": {
      "id": "trommelen-2023",
      "title": "The anabolic response to protein ingestion during recovery from exercise has no upper limit in magnitude and duration in vivo in humans",
      "authors": "Jorn Trommelen et al.",
      "journal": "Cell Reports Medicine",
      "year": "2023",
      "url": "https://doi.org/10.1016/j.xcrm.2023.101324",
      "doi": "10.1016/j.xcrm.2023.101324",
      "pmid": "38118410"
    },
    "references": [
      {
        "id": "trommelen-2023",
        "title": "The anabolic response to protein ingestion during recovery from exercise has no upper limit in magnitude and duration in vivo in humans",
        "authors": "Jorn Trommelen et al.",
        "journal": "Cell Reports Medicine",
        "year": "2023",
        "url": "https://doi.org/10.1016/j.xcrm.2023.101324",
        "doi": "10.1016/j.xcrm.2023.101324",
        "pmid": "38118410"
      }
    ],
    "sections": [
      {
        "id": "finding",
        "title": "研究发现",
        "paragraphs": [
          "一次抗阻运动后，100 g乳蛋白相较25 g，在12小时观察期内带来更大、更持久的蛋白合成反应。这对该条件下“超过20–30 g便无法利用”的固定上限提出挑战。"
        ]
      },
      {
        "id": "limits",
        "title": "范围与局限",
        "paragraphs": [
          "36名健康、平时有活动的年轻男性，随机摄入0、25或100 g乳蛋白，每组12人。",
          "只测试了三种剂量、一次运动及12小时。标题中的“没有上限”不能解释为无限收益、最佳单餐剂量或长期安全性已获证明。研究没有在总量相同下比较一次100 g与四餐各25 g，也未测量数月后的增肌或力量。"
        ]
      },
      {
        "id": "sample",
        "title": "研究人群与样本",
        "paragraphs": [
          "36名健康、平时有活动的年轻男性，随机摄入0、25或100 g乳蛋白，每组12人。"
        ]
      },
      {
        "id": "exposure",
        "title": "暴露或干预",
        "paragraphs": [
          "双盲平行组试验；全身抗阻运动后使用内源标记乳蛋白与静脉稳定同位素示踪。"
        ]
      },
      {
        "id": "outcomes",
        "title": "观察结局",
        "paragraphs": [
          "氨基酸出现与利用、肌肉及全身蛋白合成、蛋白平衡与氧化。"
        ]
      },
      {
        "id": "duration",
        "title": "时间范围",
        "paragraphs": [
          "一次运动和试验饮料后的12小时。"
        ]
      },
      {
        "id": "funding",
        "title": "研究资金来源",
        "paragraphs": [
          "所查阅正文中未发现独立的研究资金声明。利益声明写明FrieslandCampina未参与资助、数据收集、分析或稿件准备。"
        ]
      },
      {
        "id": "conflicts",
        "title": "研究利益关系",
        "paragraphs": [
          "Glenn A.A. van Lieshout为FrieslandCampina雇员。论文链接Trommelen和van Loon的Maastricht University个人页面供查阅职业资助经历；本次未全面审计这些历史关系。"
        ]
      },
      {
        "id": "basis",
        "title": "导读范围",
        "paragraphs": [
          "查阅PMC正文的设计、结果与关键图表、局限、参与者标准及声明；未重算补充材料中的个体数据。"
        ],
        "links": [
          {
            "label": "PubMed Central 全文",
            "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10772463/"
          }
        ]
      }
    ]
  }
}
